C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/63 (2006.01) A61K 35/76 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C12N 7/01 (2006.01) C12N 15/861 (2006.01)
Patent
CA 2545696
Viral vectors and methods of making such vectors are described that preferentially kill neoplastic but not normal cells, the preferred vector being an adenovirus that has the endogenous promoters in the E1A and/or E4 regions substituted with a tumor specific promoter which is preferably E2F responsive.
La présente invention concerne des vecteurs viraux et des méthodes permettant d'élaborer de tels vecteurs, lesquels vecteurs, de préférence, tuent les cellules néoplasiques mais pas les cellules normales. Le vecteur privilégié dans cette invention est un adénovirus dont les promoteurs endogènes dans les régions E1A et/ou E4 sont substitués par un promoteur spécifique des tumeurs qui est, de préférence, sensible à E2F.
Fattaey Ali
Hermiston Terry
Johnson Leisa
Laquerre Sylvie
Shen Jerry Yuqiao
Fetherstonhaugh & Co.
Onyx Pharmaceuticals Inc.
LandOfFree
An oncolytic adenovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with An oncolytic adenovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An oncolytic adenovirus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1369748